Sarissa Biomedical Ltd Sarissa

  Barclays Venture Centre t: +44 (0) 870 961 9991  
  Sir William Lyons Road f: +44 (0) 24 7601 0313  
  Coventry e:  
  CV4 7EZ w:  
  United Kingdom      
  Prof. Nicholas Dale Technical Director  
  Dr. Everard Mascarenhas Business Manager  
1 Neurochemical biosensors    
2 Purine biosensors    
3 in vivo and in vitro neuro biosensors    
4 Potentiostat    

Sarissa is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines and other neurochemicals, as indicators of neurological activity / disorders and has a product design platform that offers exquisite sensitivity, coupled with a broad linear activity range and high levels of accuracy and reproducibility. These biosensors are designed for in vitro and in vivo studies for research and diagnostic applications.

Crucial to the Sarissa's highly differentiated technology are the unique methods by which active enzyme-based layers are deposited onto the surface of the sensor. In the case of the ATP sensor (sarissaprobe®-ATP) the enzyme matrix includes glycerol kinase and glycerol-3-phosphate oxidase, deposited onto the surface of a Pt/Ir microelectrode.


© 2015 Captum Capital Limited. All worldwide rights reserved